» Articles » PMID: 32557189

Extracting and Selecting Robust Radiomic Features from PET/MR Images in Nasopharyngeal Carcinoma

Overview
Publisher Springer
Date 2020 Jun 20
PMID 32557189
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: This work aims to study the variation, robustness, and feature redundancy of PET/MR radiomic features in the primary tumor of nasopharyngeal carcinoma (NPC).

Procedures: PET/MR scans of 21 NPC patients were used in this study. The primary tumor volumes were defined using PET, T2-weighted-MR (T2-MR), and diffusion-weighted MR (DW-MR) images. A random-dilation-erosion method was used to simulate 10 sets of tumor volumes for identifying features invariant with manual segmentation uncertainties. Feature robustness was evaluated against imaging modalities, pixel sizes, slice thickness, and grey-level bin sizes using intraclass correlation coefficient (ICC) and spearman correlation coefficient. Feature redundancy was analyzed using the hierarchical cluster analysis.

Results: Voxel size of 0.5 × 0.5 × 1.0 mm was found optimal for robust feature extraction from PET and MR. Normalized grey level of 64 and 128 was suggested for PET and MR, respectively. The features from wavelet-transformed images were less stable than those from the original images. The robustness analysis and volume correlation analysis identified 335 (62.04 %) PET features, 240 (44.44 %) T2-MR features, and 366 (67.78 %) DW-MR features. The cluster analysis grouped PET, T2-MR, and DW-MR features into 106, 83, and 133 representative features, respectively.

Conclusions: The present study analyzed and identified robust features extracted from tumor volumes on PET/MR, which can provide guidance and promote standardization for PET/MR radiomic studies in NPC.

Citing Articles

Recent advances in early detection of nasopharyngeal carcinoma.

Jiang W, Zheng B, Wei H Discov Oncol. 2024; 15(1):365.

PMID: 39177900 PMC: 11343961. DOI: 10.1007/s12672-024-01242-3.


Mitigating the impact of image processing variations on tumour [F]-FDG-PET radiomic feature robustness.

Ramlee S, Manavaki R, Aloj L, Escudero Sanchez L Sci Rep. 2024; 14(1):16294.

PMID: 39009706 PMC: 11251269. DOI: 10.1038/s41598-024-67239-8.


Magnetic resonance imaging based on radiomics for differentiating T1-category nasopharyngeal carcinoma from nasopharyngeal lymphoid hyperplasia: a multicenter study.

Cheng J, Su W, Wang Y, Zhan Y, Wang Y, Yan S Jpn J Radiol. 2024; 42(7):709-719.

PMID: 38409300 DOI: 10.1007/s11604-024-01544-0.


Optimization and validation of voxel size-related radiomics variability by combatting batch effect harmonization in pulmonary nodules: a phantom and clinical study.

Zhuo Y, Shen J, Zhan Y, Tian Y, Yu M, Yang S Quant Imaging Med Surg. 2023; 13(9):6139-6151.

PMID: 37711807 PMC: 10498235. DOI: 10.21037/qims-22-992.


A diagnosis model in nasopharyngeal carcinoma based on PET/MRI radiomics and semiquantitative parameters.

Feng Q, Liang J, Wang L, Ge X, Ding Z, Wu H BMC Med Imaging. 2022; 22(1):150.

PMID: 36038819 PMC: 9422112. DOI: 10.1186/s12880-022-00883-6.


References
1.
An X, Wang F, Ding P, Deng L, Jiang W, Zhang L . Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy. Cancer. 2011; 117(16):3750-7. DOI: 10.1002/cncr.25932. View

2.
Peng H, Tang L, Chen B, Chen L, Li W, Mao Y . Optimizing the induction chemotherapy regimen for patients with locoregionally advanced nasopharyngeal Carcinoma: A big-data intelligence platform-based analysis. Oral Oncol. 2018; 79:40-46. DOI: 10.1016/j.oraloncology.2018.02.011. View

3.
Tang X, Li Y, Liang S, Jiang W, Liu F, Ge W . Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study. Lancet Oncol. 2018; 19(3):382-393. DOI: 10.1016/S1470-2045(18)30080-9. View

4.
Lai V, Khong P . Updates on MR imaging and ¹⁸F-FDG PET/CT imaging in nasopharyngeal carcinoma. Oral Oncol. 2013; 50(6):539-48. DOI: 10.1016/j.oraloncology.2013.05.005. View

5.
Lambin P, Leijenaar R, Deist T, Peerlings J, de Jong E, van Timmeren J . Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017; 14(12):749-762. DOI: 10.1038/nrclinonc.2017.141. View